Sinclair Pharma PLC (LON:SPH) will be posting its Y 2017 quarterly earnings results before the market opens on Tuesday, September 19th. Analysts expect Sinclair Pharma PLC to post earnings of ($0.01) per share for the quarter.
Shares of Sinclair Pharma PLC (LON SPH) opened at 28.625 on Tuesday. The stock’s 50 day moving average is GBX 29.21 and its 200-day moving average is GBX 31.25. The stock’s market cap is GBX 143.75 million. Sinclair Pharma PLC has a one year low of GBX 26.00 and a one year high of GBX 36.35.
Several research firms have recently issued reports on SPH. Peel Hunt restated a “buy” rating and set a GBX 68 ($0.88) price objective on shares of Sinclair Pharma PLC in a report on Tuesday, July 11th. Stifel Nicolaus restated a “buy” rating and set a GBX 71 ($0.92) price objective on shares of Sinclair Pharma PLC in a report on Tuesday, July 11th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of GBX 54 ($0.70).
Sinclair Pharma PLC Company Profile
Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.
Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.